RANK, RANKL and osteoprotegerin in bone biology and disease
dc.contributor.author | Wright, H. L. | * |
dc.contributor.author | McCarthy, Helen S. | * |
dc.contributor.author | Middleton, Jim F. | * |
dc.contributor.author | Marshall, Michael J. | * |
dc.date.accessioned | 2011-12-16T17:07:40Z | |
dc.date.available | 2011-12-16T17:07:40Z | |
dc.date.issued | 2008-12-20 | |
dc.identifier.citation | Wright, H. L., McCarthy, H. S., Middleton, J. F., & Marshall, M. J. (2009). RANK, RANKL and osteoprotegerin in bone biology and disease. Current Reviews in Musculoskeletal Medicine, 2(1), 56-64. https://doi.org/10.1007/s12178-009-9046-7 | |
dc.identifier.issn | 1935-973X | en |
dc.identifier.doi | 10.1007/s12178-009-9046-7 | |
dc.identifier.uri | http://hdl.handle.net/10034/197718 | |
dc.description | This article is not available through ChesterRep. | |
dc.description.abstract | This review discusses the latest news and views on the mechanisms controlling bone resorption in normal and pathological conditions. | |
dc.language.iso | en | en |
dc.relation.url | http://www.springerlink.com/index/10.1007/s12178-009-9046-7 | en |
dc.subject | osteoprotegerin (OPG) | en |
dc.subject | receptor activator of nuclear factor kappa beta (RANK) | en |
dc.subject | receptor activator of nuclear factor kappa beta ligand (RANKL) | en |
dc.subject | bone disease | en |
dc.title | RANK, RANKL and osteoprotegerin in bone biology and disease | en |
dc.type | Article | |
dc.identifier.eissn | 1935-9748 | |
dc.contributor.department | Charles Salt Centre, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust in Oswestry | |
dc.identifier.journal | Current Reviews in Musculoskeletal Medicine | en |
dc.date.accepted | 2018-11-25 | |
html.description.abstract | This review discusses the latest news and views on the mechanisms controlling bone resorption in normal and pathological conditions. |